Status:
COMPLETED
Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
Lead Sponsor:
AstraZeneca
Conditions:
Breast Cancer
Eligibility:
FEMALE
Brief Summary
the purpose of this study is to describe the way Faslodex is used in France, in patients suffering from initial breast cancer, that is to evaluate Faslodex treatment duration and to determine patients...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients suffering from initial breast cancer, treated with Faslodex, treatment which was stopped during 2007
Exclusion
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT00681369
Start Date
May 1 2007
End Date
June 1 2007
Last Update
January 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.